Abstract:Background Improving targeted therapy, and reducing adverse side effects of antitumor drugs toward normal cells with simultaneous bioimaging properties are being developed in pharmaceutical industries. In this study, N doped-carbon quantum dot (CQD) with ultra-high quantum yield (QY) was synthesized and its surface was modified with folic acid as the targeted anticancer agent. Methods CQD was synthesized by one-step hydrothermal method. The impact of operating parameters such as pyrolysis temperature, time, and pH on the QY and surface charge was investigated. Then, the CQD surface was modified with folic acid as the targeted anticancer agent followed by doxorubicin (DOX) conjugation on the surface. Cytotoxicity of CQD-FA and CQD-FA-DOX upon 4T1, MCF7 and PC12 cell lines were examined. Furthermore, fluorescent microscopy imaging and flow cytometry analysis for various cell lines were applied to evaluate CQD-FA bioimaging property. In addition, the efficacy of the formulation on the BALB/c mice bearing breast cancer tumors was investigated. Results In CQD preparation, average particle size of 7 nm was confirmed by the characterization results. With optimum synthesis conditions of pH = 11, time = 8 h and temperature = 160 °C, QY was about 90%. XPS analysis confirmed formation of N doped CQD. DOX loading efficiency was 88.6% and about 86% of the loaded DOX was released from CQD-FA-DOX after 72 h at pH = 5.5. Cytotoxicity analysis confirmed a higher toxicity effect of CQD-FA-DOX toward cancerous cell lines (4T1, MCF7) in comparison to free DOX. This nanocarrier could act smartly in identifying folate receptor positive cancerous cells and enter mainly by the receptor-mediated route. In vivo results showed that cellular internalization of CQD-FA-DOX was greater than free DOX, in which the tumor growth in mice treated with CQD-FA-DOX was lower than free DOX. In addition, ex vivo analysis confirmed lower side effects of CQD-FA-DOX on the main organs of mice in comparison to the free drug group. Conclusion This new synthesized carrier can be a suitable platform for drug delivery applications with lower side effects, targeted cellular uptake and bioimaging properties.

Synthesis of metformin-derived fluorescent quantum dots: uptake, cytotoxicity, and inhibition in human breast cancer cells through autophagy pathway

Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumors

Quantum Dots: Synthesis, Antibody Conjugation, and HER2-Receptor Targeting for Breast Cancer Therapy

Enhancement of targeted therapy in combination with metformin on human breast cancer cell lines

Metformin as a Potential Therapeutic Agent in Breast Cancer: Targeting miR-125a Methylation and Epigenetic Regulation

Enhanced Response of Metformin Towards the Cancer Cells Due to Synergism with Multi-walled Carbon Nanotubes in Photothermal Therapy.

Metformin-loaded chitosan nanoparticles augment silver nanoparticle-induced radiosensitization in breast cancer cells during radiation therapy

Sugar-Coated Nanobullet: Growth Inhibition of Cancer Cells Induced by Metformin-Loaded Glyconanoparticles.

Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways

N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications

Ultrasound-assisted encapsulating folic acid-based carbon quantum dots within breast cancer cell-derived exosomes as a co-receptors-mediated anticancer nanocarrier for enhanced breast cancer therapy

Carbonized polymer dots derived from metformin and L-arginine for tumor cell membrane- and mitochondria-dual targeting therapy

Real-time monitoring of glucose metabolism and effects of metformin on HepG2 cells using 13C in-cell NMR spectroscopy

Imaging and Inhibition of Multi-Drug Resistance in Cancer Cells Via Specific Association with Negatively Charged CdTe Quantum Dots.

Functionalized Selenium Nanoparticles Synergizes With Metformin to Treat Breast Cancer Cells Through Regulation of Selenoproteins

Synthesis and characterization of some Metal ions complexes with mixed ligand of azo dye and Metformin and evaluation of its effectiveness on the growth of some pathogenic bacteria clinically isolated and study of its Toxicity on normal and cancerous Hepatocytes

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies

Metformin Loaded Zein Polymeric Nanoparticles to Augment Antitumor Activity against Ehrlich Carcinoma via Activation of AMPK Pathway: D-Optimal Design Optimization, In Vitro Characterization, and In Vivo Study

Near-infrared phosphorescent cyclometalated platinum (II) and iridium (III) complexes with metformin moiety: Design and study towards anticancer theranostic agents

Milk-derived multi-fluorescent graphene quantum dot-based cancer theranostic system

Quantum Dots Functionalized Polymeric Nanoparticles as Cancer Theranostics: An Advanced Nanomedicine Strategy